Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomised Phase II Study Comparing the Efficiency of a HT Concomitant With RT vs RT Alone in the Salvage of Patients With a Detectable PSA After Prostatectomy

NCT01994239 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01994239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01994239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomised Phase II Study Comparing the Efficiency of a HT Concomitant With RT vs RT Alone in the Salvage of Patients With a Detectable PSA After Prostatectomy
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 31, 2012
Completion date
March 31, 2025
Enrollment
120 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of prostate